超越基线:绘制疾病的特定环境监管格局
1Section of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Trends in genetics : TIG
|March 13, 2026
概括
许多与疾病相关的遗传变异在标准研究中缺乏监管联系. 在不同条件下识别的特定环境表达量的特征位点 (eQTLs) 更好地匹配疾病位点,表明它们在遗传疾病中的重要性.
科学领域:
- 遗传学 是一个遗传学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 全基因组关联研究 (GWAS) 确定了许多与疾病相关的基因间变异,通常被认为会影响基因调节.
- 标准表达量的特征位点 (eQTL) 研究将一些位点与基因表达变化联系起来,但许多疾病位点在基线成年组织中缺乏可检测的效应.
- 标准eQTL和与疾病相关的基位之间存在差异,表明在正常条件下没有捕获的监管效应.
研究的目的:
- 审查关于特定环境的eQTL和它们与疾病相关的局部相关性的新兴证据.
- 突出环境干扰,压力和发展过渡的潜力,揭示监管效应.
- 讨论新的体外系统和机器学习方法,以确定取决于环境的监管效应.
主要方法:
- 关于GWAS,标准eQTL研究和特定背景的eQTL研究的文献综述.
- 分析新出现的证据,将特定环境的监管效应与疾病位置联系起来.
- 讨论用于识别上下文依赖的eQTL的新实验和计算方法.
主要成果:
- 在非基线条件下识别的特定环境的eQTL与标准eQTL相比,更像与疾病相关的位置.
- 环境因素,细胞压力和发育变化可以揭示静态分析中错过的调节效应.
- 新兴的体外系统和机器学习为系统检测上下文依赖的监管影响提供了有希望的途径.
结论:
- 与疾病相关的调节变异可能在特定的生物背景下而不是基线条件下发挥作用.
- 调查特定上下文的eQTL对于理解GWAS识别的非编码变体的功能影响至关重要.
- 未来的研究应该利用动态和系统生物学方法,充分阐明上下文基因调节在人类健康和疾病中的作用.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
93
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
93
Epigenetic Regulation
4.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.1K
Epigenetic Regulation
34.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Global Regulatory Systems
838
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
838
Cis-regulatory Sequences
12.1K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
12.1K


